BioNexus Gene Lab (BGLC) Return on Invested Capital (2019 - 2025)

BioNexus Gene Lab's Return on Invested Capital history runs 7 years deep, the most recent figure standing at 0.0% for Q3 2025.

• In Q3 2025, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Sep 2025 stood at 0.0% (changed 0.0% YoY), while the FY2024 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q3 2025 at BioNexus Gene Lab, up from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2021 to a low of 0.0% in Q3 2023.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Invested Capital.
• Across the five-year window, Return on Invested Capital changed 0 bps in 2021 and retreated 1 bps in 2023, its largest moves.
• BioNexus Gene Lab's Return on Invested Capital stood at 0.0% in 2021, then sank by 120 bps to 0.0% in 2022, then tumbled by 636 bps to 0.0% in 2023, then soared by 37 bps to 0.0% in 2024, then plunged by 84 bps to 0.0% in 2025.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q3 2025, Q2 2025, and Q1 2025 respectively.

Peer Comparison